Cryptos: 31,625 Exchanges: 354 Market Cap: $2,488.76B 24h Vol: $79.4B Dominance: BTC 55.5% ETH 12% ETH Gas:  5 Gwei
Seclect Currency

Fiat currencies

    Crypto Currencies

      No results for ""

      We couldn't find anything matching your search.Try again with a different term.

      Carv's Logo

      Carv - Strategic 3

      Overview Investors Founders Company Profile / Project Introduction

      Overview

      Funding Date

      June 13, 2024

      Financing amount

      --

      Valuation

      --

      Catagory

      Web3

      Subcategory

      Gaming

      About Carv - Strategic 3

      CARV, the largest modular data layer for gaming and AI, today announced a strategic investment from Double jump.tokyo Inc., the trailblazing Japanese web3 gaming company and primary developers behind Oasys, the leading layer-1 blockchain purpose-built for gamers. The alliance brings together two powerhouses in the industry, promising to drive innovation and widespread adoption of web3 gaming.

      Investors

      InvestorsTypeLocationYear Founded#Portfolio CompaniesEmail AddressSocials
      Corporate Japan 2018 6 --

      Founders & Team

      Victor Yu's Logo

      Victor Yu

      Clo G.'s Logo

      Clo G.

      Company Profile / Project Introduction

      CARV is the largest modular data layer for gaming, AI, and ∞, pioneering a future where data generates value for all. As the sole author of ERC7231, CARV has built CARV Protocol, the modular data layer which has integrated with 40+ blockchains, Google Cloud, and other identity, storage, infra and AI providers. CARV's flagship gaming superapp, CARV Play, is integrated with more than 790 web2 & 3 games and serving 2.7M+ gamers. CARV is backed by top-tier funds and ecosystems such as Temasek's Vertex Ventures, ConsenSys (developer of Metamask), Tribe Capital, IOSG Ventures, Animoca Brands, HashKey Capital, Infinity Ventures Crypto, MARBELX, and more. For more information, users can visit carv.io.

      View More
      *Fundraising Announcement: Click here